Elanco Animal Health Incorporated Common Stock (ELAN)

R&D Expenses

$92.00M

Quarterly · Period ending: · USD

ELAN logo

ELAN R&D Expenses

Latest reported$92.00M
ELAN Quarterly R&D Expenses ($63.95M → $92.00M)
High-resolution chart · PNG

ELAN r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Elanco Animal Health Incorporated Common Stock R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
92,000,000
97,000,000
93,000,000
89,000,000
92,000,000
94,000,000
81,000,000
87,000,000
89,000,000
87,000,000
79,000,000
86,000,000
81,000,000
81,000,000
80,000,000
78,000,000
82,000,000
81,000,000
92,000,000
94,000,000
94,000,000
89,000,000
112,700,000
88,100,000
59,400,000
66,800,000
67,300,000
69,900,000
68,800,000
64,100,000
61,100,000
58,900,000
61,400,000
65,200,000
62,000,000
61,900,000
63,950,000
63,950,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.